AnaCardio Revenue and Competitors
Estimated Revenue & Valuation
- AnaCardio's estimated annual revenue is currently $5.6M per year.
- AnaCardio's estimated revenue per employee is $201,000
- AnaCardio's total funding is $44M.
Employee Data
- AnaCardio has 28 Employees.
- AnaCardio grew their employee count by 47% last year.
AnaCardio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
2 | Chief Development Officer (CDO) | Reveal Email/Phone |
3 | Office Manager | Reveal Email/Phone |
4 | Business Controller | Reveal Email/Phone |
5 | Clinical Specialist | Reveal Email/Phone |
AnaCardio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $31.2M | 155 | 20% | N/A | N/A |
#2 | $5.6M | 28 | 47% | $44.2M | N/A |
What Is AnaCardio?
AnaCardio AB is a privately held Swedish, clinical stage biopharmaceutical company developing novel drugs to treat heart failure. AnaCardio was founded based on ground-breaking research from Karolinska Institutet showing improved contractility of the heart muscle through a unique and differentiated mechanism. Its lead program AC01 is planned to enter phase 2 clinical development in heart failure patients in 2022. You can find more information about AnaCardio at www.anacardio.com.
keywords:N/A
$44M
Total Funding
28
Number of Employees
$5.6M
Revenue (est)
47%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Solna
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.1M | 28 | 47% | N/A |
#2 | $4.2M | 30 | 100% | N/A |
#3 | $3.6M | 32 | 3% | N/A |
#4 | $8M | 32 | -36% | N/A |
#5 | $3.9M | 34 | 26% | N/A |